These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 20610861)
1. Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. Smith DD; Tan X; Tawfik O; Milne G; Stechschulte DJ; Dileepan KN J Physiol Pharmacol; 2010 Jun; 61(3):309-16. PubMed ID: 20610861 [TBL] [Abstract][Full Text] [Related]
2. Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice. Smith DD; Tan X; Raveendran VV; Tawfik O; Stechschulte DJ; Dileepan KN Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2612-21. PubMed ID: 22505639 [TBL] [Abstract][Full Text] [Related]
3. Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. McClelland S; Gawaz M; Kennerknecht E; Konrad CS; Sauer S; Schuerzinger K; Massberg S; Fitzgerald DJ; Belton O Atherosclerosis; 2009 Jan; 202(1):84-91. PubMed ID: 18514659 [TBL] [Abstract][Full Text] [Related]
4. Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. Kobayashi T; Tahara Y; Matsumoto M; Iguchi M; Sano H; Murayama T; Arai H; Oida H; Yurugi-Kobayashi T; Yamashita JK; Katagiri H; Majima M; Yokode M; Kita T; Narumiya S J Clin Invest; 2004 Sep; 114(6):784-94. PubMed ID: 15372102 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640 [TBL] [Abstract][Full Text] [Related]
6. Additive anti-atherogenic effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice. Tang L; Ding T; Praticò D Atherosclerosis; 2008 Aug; 199(2):265-70. PubMed ID: 18206890 [TBL] [Abstract][Full Text] [Related]
7. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis. Praticò D; Cyrus T; Li H; FitzGerald GA Blood; 2000 Dec; 96(12):3823-6. PubMed ID: 11090066 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950 [TBL] [Abstract][Full Text] [Related]
9. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809 [TBL] [Abstract][Full Text] [Related]
10. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Judkins CP; Diep H; Broughton BR; Mast AE; Hooker EU; Miller AA; Selemidis S; Dusting GJ; Sobey CG; Drummond GR Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H24-32. PubMed ID: 19837950 [TBL] [Abstract][Full Text] [Related]
11. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4. Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793 [TBL] [Abstract][Full Text] [Related]
12. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ; Waseem TC; Galkina EV Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405 [TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Smith E; Prasad KM; Butcher M; Dobrian A; Kolls JK; Ley K; Galkina E Circulation; 2010 Apr; 121(15):1746-55. PubMed ID: 20368519 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice. Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013 [TBL] [Abstract][Full Text] [Related]
15. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice. Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265 [TBL] [Abstract][Full Text] [Related]
16. TSLPR deficiency attenuates atherosclerotic lesion development associated with the inhibition of TH17 cells and the promotion of regulator T cells in ApoE-deficient mice. Wu C; He S; Peng Y; Kushwaha KK; Lin J; Dong J; Wang B; Lin J; Shan S; Liu J; Huang K; Li D J Mol Cell Cardiol; 2014 Nov; 76():33-45. PubMed ID: 25117469 [TBL] [Abstract][Full Text] [Related]
17. Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: correlation with plaque composition. Cyrus T; Ding T; Praticò D Atherosclerosis; 2010 Feb; 208(2):376-81. PubMed ID: 19735918 [TBL] [Abstract][Full Text] [Related]
18. [Impact of exogenous fibroblast growth factor 21 on atherosclerosis in apolipoprotein E deficient mice]. Wu X; Lü Y; Fu K; Wang S; Zhao D; Peng H; Fan Q; Lü Y; Xin M; Liu J Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Feb; 42(2):126-31. PubMed ID: 24735623 [TBL] [Abstract][Full Text] [Related]
19. Modulation of rat platelet activation by vessel wall-derived prostaglandin and platelet-derived thromboxane: effects of dietary fish oil on thromboxane-prostaglandin balance. Nieuwenhuys CM; Feijge MA; Offermans RF; Kester AD; Hornstra G; Heemskerk JW Atherosclerosis; 2001 Feb; 154(2):355-66. PubMed ID: 11166768 [TBL] [Abstract][Full Text] [Related]
20. Thromboxane receptor blockade improves the antiatherogenic effect of thromboxane A2 suppression in LDLR KO mice. Cyrus T; Yao Y; Ding T; Dogné JM; Praticò D Blood; 2007 Apr; 109(8):3291-6. PubMed ID: 17158227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]